BASF Walks Away From Evonik After Two Rejected Bids, Turning Investor Focus to Payout Discipline
Published on 11/19/2026 at 17:20 | Editorial boerse-global.deBASF has called off its pursuit of Evonik after the specialty chemicals group turned down two non-binding all-cash offers, ending a courtship that would have valued its rival at more than EUR 11 billion. The Ludwigshafen-based giant had weighed one more modest increase but concluded that Evonik's standalone business outlook — and the risks attached to it — did not justify a richer cheque.
The final proposal stood at EUR 24 per Evonik share, a level at which Handelsblatt reported BASF valued the company at over EUR 11 billion. Talks never deepened: according to BASF, the Evonik board declined any substantive exchange.
Chief executive Markus Kamieth had argued in WirtschaftsWoche that a combination made industrial sense and would have created a stronger chemicals player. His retreat nonetheless draws a clear line on price — BASF saw merit in the deal but would not pay beyond its own valuation to get it.
Evonik Insists on Charting Its Own Course
Evonik, for its part, held fast to independence without ruling out a role in sector consolidation. Interim chief Claus Rettig told the Frankfurter Allgemeine Zeitung the company intends to help shape that consolidation itself. Political backing for that stance came from North Rhine-Westphalia premier Hendrik Wüst, who opposed the takeover and stressed Evonik's importance as an employer in the state.
Reuters, citing people close to Evonik, reported that even a higher BASF offer could have been rejected absent a convincing industrial rationale for the merger.
Should investors sell immediately? Or is it worth buying BASF?
A Split Market Reaction
Equity investors delivered a sharply divergent verdict. Evonik shares fell as much as 23% at one point following the announcement, according to Spiegel. BASF initially gained on the news, but the advance evaporated: the stock was recently down 0.3% on the day. A day earlier, the shares had slipped as opposition to the deal built, before recovering 0.4% to EUR 51.49.
With the takeover attempt behind it, BASF reiterated its commitment to disciplined capital deployment and attractive shareholder distributions. Free cash flow stood at roughly minus EUR 1 billion after nine months of 2026, putting the payout pledge under scrutiny.
Attention now shifts to the capital markets day on 24 November 2026, where investors will press management on how distribution targets square with that cash flow trajectory.
Portfolio Housekeeping Continues
Elsewhere, BASF has been reshaping its operations. On 12 November it agreed to sell its global mining solutions business to SNF, a deal covering the Cork production site and around 140 employees. Completion is targeted for 2027, subject to regulatory approval and customary closing conditions.
Its Agricultural Solutions unit said on Monday it will market its Nemasphere technology worldwide, with BASF putting peak sales potential at more than EUR 300 million. Soy varieties carrying the technology are slated to launch in the US and Brazil from 2028.
BASF also struck a cooperation with DWE to speed the delivery of modular plants for sustainable methanol production, combining DWE's power-to-liquid technology with BASF's SYNSPIRE catalysts.
Ad
BASF Stock: New Analysis - 19 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
